Cargando…

Difelikefalin: A Novel Therapy for Dialysis Patient Care

Detalles Bibliográficos
Autores principales:	Watnick, Suzanne, Butler, Catherine R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386091/ https://www.ncbi.nlm.nih.gov/pubmed/35991692 http://dx.doi.org/10.1016/j.xkme.2022.100519

Ejemplares similares

The Role of Dialysis Organizations in Promoting and Facilitating Access to Nondialytic Treatment Options
por: Butler, Catherine R., et al.
Publicado: (2022)

Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients
por: Fishbane, Steven, et al.
Publicado: (2020)

Assessment of the physical dependence potential of difelikefalin: Randomized placebo‐controlled study in patients receiving hemodialysis
por: Spencer, Robert H., et al.
Publicado: (2023)

Difelikefalin in the Treatment of Chronic Kidney Disease-Associated Pruritus: A Systematic Review
por: Wala, Kamila, et al.
Publicado: (2022)

Safety and Effectiveness of Difelikefalin in Patients With Moderate-to-Severe Pruritus Undergoing Hemodialysis: An Open-Label, Multicenter Study
por: Weiner, Daniel E., et al.
Publicado: (2022)

Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users
por: Shram, Megan J., et al.
Publicado: (2021)

Pharmacokinetics, Metabolism, and Excretion of Intravenous [14C]Difelikefalin in Healthy Subjects and Subjects on Hemodialysis
por: Stark, Jeffrey G., et al.
Publicado: (2023)

Hemodialysis and COVID-19: An Achilles’ Heel in the Pandemic Health Care Response in the United States
por: Weiner, Daniel E., et al.
Publicado: (2020)

Efficacy and Safety of Difelikefalin in Japanese Patients With Moderate to Severe Pruritus Receiving Hemodialysis: A Randomized Clinical Trial
por: Narita, Ichiei, et al.
Publicado: (2022)

Safety and Tolerability of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis From the Phase 3 Clinical Trial Program
por: Fishbane, Steven, et al.
Publicado: (2022)

Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression: A randomized, double‐blind, placebo‐controlled trial
por: Viscusi, Eugene R., et al.
Publicado: (2021)

Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies
por: Topf, Joel, et al.
Publicado: (2022)

COVID-19 and Kidney Failure in the Acute Care Setting: Our Experience From Seattle
por: Durvasula, Raghu, et al.
Publicado: (2020)

Cost Effectiveness of Difelikefalin Compared to Standard Care for Treating Chronic Kidney Disease Associated Pruritus (CKD-aP) in People with Kidney Failure Receiving Haemodialysis
por: Thokala, Praveen, et al.
Publicado: (2023)

A Blueprint for Planning Person-Centered Dialysis Care
por: Kemp, Philip, et al.
Publicado: (2021)

To Dialysis and Beyond: The Nephrologist’s Responsibility for Advance Care Planning
por: Ramer, Sarah J., et al.
Publicado: (2020)

Dialysis therapy for Syrian refugees in Lebanon: a call for action
por: Karah, Nabil, et al.
Publicado: (2018)

Impact of high-dose diuretic combination therapy on volume status in peritoneal dialysis patients
por: Kim, Yong-Lim
Publicado: (2019)

When to Start Dialysis in Elderly Patients
por: Rostami, Zohreh
Publicado: (2013)

Dialysis headache
por: PERES, Mario Fernando Prieto
Publicado: (2022)

Peritoneal Dialysis
por: Taskapan, Hulya, et al.
Publicado: (2011)

Peritoneal Dialysis as an Alternative Choice for Renal Replacement Therapy in Emergency Department
por: Najafi, Iraj
Publicado: (2014)

Telehealth for Home Dialysis in COVID-19 and Beyond: A Perspective From the American Society of Nephrology COVID-19 Home Dialysis Subcommittee
por: Lew, Susie Q., et al.
Publicado: (2021)

The COVID-19 infection in dialysis: are home-based renal replacement therapies a way to improve patient management?
por: Cozzolino, Mario, et al.
Publicado: (2020)

Chronic exit-site care using povidone–iodine versus normal saline in peritoneal dialysis patients
por: Young Do, Jun
Publicado: (2014)

Dialysis Access Dysfunction
por: Yevzlin, Alexander, et al.
Publicado: (2012)

Peritoneal dialysis: why not?
por: Andreoli, Maria Claudia Cruz, et al.
Publicado: (2023)

Pain Management in Patients With Kidney Disease—A Nephrologist and Dialysis Care Team Responsibility: KDOQI Controversies Series
por: Combs, Sara A., et al.
Publicado: (2020)

Addressing the Need for New Models of Care for Older Adults Receiving Long-term Dialysis
por: Bowling, C. Barrett
Publicado: (2019)

The new Brazilian Dialysis Census
por: Barretti, Pasqual
Publicado: (2022)

Urgent-start peritoneal dialysis
por: Pellizzari, Caio, et al.
Publicado: (2022)

Reflections on End-of-Life Dialysis
por: Tzanno-Martins, Carmen
Publicado: (2018)

Dialysis Decision Making and the Patient Experience: Lessons From Pakistan
por: Rizzolo, Katherine, et al.
Publicado: (2022)

Atrial Fibrillation in Patients with End-stage Kidney Disease on Dialysis
por: Watanabe, Hiroshi, et al.
Publicado: (2018)

Sex hormones impact vascular calcification and fracture in dialysis patients
por: An, Won Suk
Publicado: (2020)

Remote Patient Monitoring: An Important Tool in Advancing Home Dialysis
por: Whitlow, Michael, et al.
Publicado: (2019)

Influence of Functional Impairment on Prognosis in Hospitalized Elderly Patients on Dialysis
por: Tamura, Kouichi, et al.
Publicado: (2023)

Apixaban Dosing in Patients With Kidney Failure Treated With Peritoneal Dialysis
por: Lidgard, Benjamin, et al.
Publicado: (2023)

Telemedicine and peritoneal dialysis: the future is now
por: Fernandes, Natália Maria da Silva, et al.
Publicado: (2022)

Living is very dangerous: dialysis in the pandemic
por: da Silva, Dirceu Reis
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_82061m0ukq1q839oas6976el8f